We are live on ! Find out more
CCS

Crosspoint Capital Strategies Portfolio holdings

AUM $50.4M
1-Year Est. Return 15.37%
This Fund
S&P 500
This Quarter Est. Return
+34.35%
1 Year Est. Return
-15.37%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$129M
AUM Growth
+$14.8M
Cap. Flow
-$7.03M
Cap. Flow %
-5.44%
Top 10 Hldgs %
32.12%
Holding
194
New
55
Increased
10
Reduced
22
Closed
72

Top Sells

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$5.83M
2
CHGG icon
Chegg
CHGG
+$4.05M
3
SUPN icon
Supernus Pharmaceuticals
SUPN
+$3.85M
4
W icon
Wayfair
W
+$3.84M
5
MDXG icon
MiMedx Group
MDXG
+$3.69M

Sector Composition

Rank Sector Weight
1 Technology 27.65%
2 Consumer Discretionary 20.05%
3 Healthcare 19.63%
4 Consumer Staples 9.11%
5 Industrials 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUTR
101
DELISTED
Cutera, Inc.
CUTR
$8K 0.01%
+203
New +$6.69K
HCCI
102
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$8K 0.01%
+390
New +$7.27K
WIFI
103
DELISTED
Boingo Wireless, Inc.
WIFI
$8K 0.01%
379
-71
-16% -$1.3K
GLUU
104
DELISTED
Glu Mobile Inc.
GLUU
$8K 0.01%
+2,258
New +$7.1K
KOL
105
DELISTED
VanEck Vectors Coal ETF
KOL
$8K 0.01%
+57
New +$8.29K
NTRI
106
DELISTED
NutriSystem, Inc.
NTRI
$8K 0.01%
+150
New +$8.12K
CHUBA
107
DELISTED
CommerceHub, Inc. Series A Common Stock
CHUBA
$8K 0.01%
+352
New +$7.15K
AAWW
108
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$8K 0.01%
+119
New +$7.44K
CENX icon
109
Century Aluminum
CENX
$4.54B
$7K 0.01%
+408
New +$7.04K
AVEO
110
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$7K 0.01%
+204
New +$6.31K
KEM
111
DELISTED
KEMET Corporation
KEM
$7K 0.01%
354
-166
-32% -$3.14K
AWF
112
AllianceBernstein Global High Income Fund
AWF
$875M
$6K ﹤0.01%
431
SWIR
113
DELISTED
Sierra Wireless
SWIR
$6K ﹤0.01%
270
DDM icon
114
ProShares Ultra Dow30
DDM
$586M
$3K ﹤0.01%
+192
New +$3.3K
QLD icon
115
ProShares Ultra QQQ
QLD
$14.2B
$3K ﹤0.01%
416
SPXL icon
116
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.02B
$3K ﹤0.01%
91
-6
-6% -$216
SSO icon
117
ProShares Ultra S&P500
SSO
$8.53B
$3K ﹤0.01%
280
-16
-5% -$186
TQQQ icon
118
ProShares UltraPro QQQ
TQQQ
$36.9B
$3K ﹤0.01%
696
-24
-3% -$110
UDOW icon
119
ProShares UltraPro Dow 30
UDOW
$874M
$3K ﹤0.01%
+200
New +$3.26K
CNA icon
120
CNA Financial
CNA
$13.2B
$1K ﹤0.01%
+10
New +$500
RMR icon
121
The RMR Group
RMR
$333M
$1K ﹤0.01%
13
FTR
122
DELISTED
Frontier Communications Corp.
FTR
$1K ﹤0.01%
44
-2
-4% -$28
AAOI icon
123
Applied Optoelectronics
AAOI
$9.63B
-50,171
Closed -$3.1M
AMD icon
124
Advanced Micro Devices
AMD
$778B
-468
Closed -$6K
AZTA icon
125
Azenta
AZTA
$1.47B
-251
Closed -$5K

Similar funds

Crosspoint Capital Strategies's Q3 2017 Portfolio in Review

As of Q3 2017, Crosspoint Capital Strategies held 194 positions worth $129M, up 13% from $114M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Crosspoint Capital Strategies withdrew a net $7.03M in Q3 2017, closing 72 positions and reducing 22 holdings. Its most notable exit was Clovis Oncology, Inc., an estimated $5.83M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Crosspoint Capital Strategies opened a new position in Boeing worth $3.99M.

  • Crosspoint Capital Strategies's largest Q3 2017 buy was Boeing: 15,706 shares worth $3.99M.
  • Crosspoint Capital Strategies added most to Control4 Corporation in Q3 2017, an estimated $3.57M increase.
  • Crosspoint Capital Strategies's biggest Q3 2017 reduction was Chegg, cutting an estimated $4.05M.
  • Crosspoint Capital Strategies fully exited Clovis Oncology, Inc. in Q3 2017, selling an estimated $5.83M.
  • Crosspoint Capital Strategies's ten largest holdings make up 32% of its $129M portfolio in Q3 2017.
  • Crosspoint Capital Strategies opened 55 new positions and closed 72 in Q3 2017.
  • Crosspoint Capital Strategies's portfolio value rose 13% quarter-over-quarter to $129M.

Based on Crosspoint Capital Strategies's 13F filing for Q3 2017, filed 6 Nov 2017.